Physician perspective on incorporation of oncology patient quality-of-life, fatigue, and pain assessment into clinical practice

Journal of Oncology Practice

Volumn 10, Issue 4, 2013, Pages 248-253

  Hubbard, Joleen M ^a   Grothey, Axel F ^a   McWilliams, Robert R ^a   Buckner, Jan C ^a   Sloan, Jeff A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; IRINOTECAN;

ALTERNATIVE MEDICINE; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CLINICAL PATHWAY; CLINICAL PRACTICE; COLORECTAL CANCER; ELECTRONIC MEDICAL RECORD; ERECTILE DYSFUNCTION; FATIGUE; HUMAN; INTERPERSONAL COMMUNICATION; MAJOR CLINICAL STUDY; NURSE PRACTITIONER; ONCOLOGY; PAIN ASSESSMENT; PALLIATIVE THERAPY; PATIENT EDUCATION; PATIENT REFERRAL; PHYSICIAN ASSISTANT; PHYSICIAN ATTITUDE; QUALITY OF LIFE; QUESTIONNAIRE; SYMPTOM ASSESSMENT; INFORMATION PROCESSING; NEOPLASMS; PAIN MEASUREMENT; PATHOPHYSIOLOGY; PHYSICIAN; PROCEDURES; PSYCHOLOGY; TREATMENT OUTCOME;

DATA COLLECTION; FATIGUE; HUMANS; MEDICAL ONCOLOGY; NEOPLASMS; NURSE PRACTITIONERS; PAIN MEASUREMENT; PHYSICIAN ASSISTANTS; PHYSICIANS; QUALITY OF LIFE; SURVEYS AND QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 84923290298     PISSN: 15547477     EISSN: 1935469X     Source Type: Journal    
DOI: 10.1200/JOP.2013.001276     Document Type: Article

References (50)

1. Velikova G, Keding A, Harley C, et al: Patients report improvements in continuity of care when quality of life assessments are used routinely in oncology practice: Secondary outcomes of a randomised controlled trial. Eur J Cancer 46:2381-2388, 2010
2. Reilly CM, Bruner DW, Mitchell SA, et al: A literature synthesis of symptom prevalence and severity in persons receiving active cancer treatment. Support Care Cancer 21:1525-1550, 2013
3. Bower JE: Behavioral symptoms in patients with breast cancer and survivors. J Clin Oncol 26:768-777, 2008
4. Butt Z, Wagner LI, Beaumont JL, et al: Longitudinal screening and management of fatigue, pain, and emotional distress associated with cancer therapy. Support Care Cancer 16:151-159, 2008
5. Eton DT, Fairclough DL, Cella D, et al: Early change in patient-reported health during lung cancer chemotherapy predicts clinical outcomes beyond those predicted by baseline report: Results from Eastern Cooperative Oncology Group Study 5592. J Clin Oncol 21:1536-1543, 2003
6. Gotay CC, Kawamoto CT, Bottomley A, et al: The prognostic significance of patient-reported outcomes in cancer clinical trials. J Clin Oncol 26:1355-1363, 2008
7. Maione P, Perrone F, Gallo C, et al: Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: A prognostic analysis of the multicenter Italian lung cancer in the elderly study. J Clin Oncol 23:6865-6872, 2005
8. Montazeri A: Quality of life data as prognostic indicators of survival in cancer patients: An overview of the literature from 1982 to 2008. Health Qual Life Outcomes 7:102, 2009
9. Sloan JA, Zhao X, Novotny PJ, et al: Relationship between deficits in overall quality of life and non-small-cell lung cancer survival. J Clin Oncol 30:1498-1504, 2012
10. Brundage M, Blazeby J, Revicki D, et al: Patient-reported outcomes in randomized clinical trials: Development of ISOQOL reporting standards. Qual Life Res 22:1161-1175, 2013
11. Dworkin RH, Turk DC, Katz NP, et al: Evidence-based clinical trial design for chronic pain pharmacotherapy: A blueprint for ACTION. Pain 152:S107-S115, 2011
12. Turk DC, Dworkin RH, Burke LB, et al: Developing patient-reported outcome measures for pain clinical trials: IMMPACT recommendations. Pain 125:208-215, 2006
13. Dworkin RH, Turk DC, Peirce-Sandner S, et al: Considerations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendations. Pain 153:1148-1158, 2012
14. Serlin RC, Mendoza TR, Nakamura Y, et al: When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain 61:277-284, 1995
15. Li KK, Harris K, Hadi S, et al: What should be the optimal cut points for mild, moderate, and severe pain? J Palliat Med 10:1338-1346, 2007
16. Miaskowski C, Dodd MJ, West C, et al: Lack of adherence with the analgesic regimen: A significant barrier to effective cancer pain management. J Clin Oncol 19:4275-4279, 2001
17. Miaskowski C, Dodd M, West C, et al: Randomized clinical trial of the effectiveness of a self-care intervention to improve cancer pain management. J Clin Oncol 22:1713-1720, 2004
18. Barsevick AM, Cleeland CS, Manning DC, et al: ASCPRO recommendations for the assessment of fatigue as an outcome in clinical trials. J Pain Symptom Manage 39:1086-1099, 2010
19. Curt GA, Breitbart W, Cella D, et al: Impact of cancer-related fatigue on the lives of patients: New findings from the Fatigue Coalition. Oncologist 5:353-360, 2000
20. Hamilton J, Butler L, Wagenaar H, et al: The impact and management of cancer-related fatigue on patients and families. Can Oncol Nurs J 11:192-198, 2001
21. Cella D, Lai JS, Stone A: Self-reported fatigue: One dimension or more? Lessons from the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) questionnaire. Support Care Cancer 19:1441-1450, 2011
22. Ganz PA, Kwan L, Stanton AL, et al: Quality of life at the end of primary treatment of breast cancer: First results from the moving beyond cancer randomized trial. J Natl Cancer Inst 96:376-387, 2004
23. Ferrans CE, Powers MJ: Quality of life index: Development and psychometric properties. ANS Adv Nurs Sci 8:15-24, 1985
24. Montazeri A: Health-related quality of life in breast cancer patients: A bibliographic review of the literature from 1974 to 2007. J Exp Clin Cancer Res 27:32, 2008
25. Efficace F, Therasse P, Piccart MJ, et al: Health-related quality of life parameters as prognostic factors in a nonmetastatic breast cancer population: An international multicenter study. J Clin Oncol 22:3381-3388, 2004
26. Ganz PA, Lee JJ, Siau J: Quality of life assessment: An independent prognostic variable for survival in lung cancer. Cancer 67:3131-3135, 1991
27. Jerkeman M, Kaasa S, Hjermstad M, et al: Health-related quality of life and its potential prognostic implications in patients with aggressive lymphoma: A Nordic Lymphoma Group Trial. Med Oncol 18:85-94, 2001
28. Huschka MM, Mandrekar SJ, Schaefer PL, et al: A pooled analysis of quality of life measures and adverse events data in north central cancer treatment group lung cancer clinical trials. Cancer 109:787-795, 2007
29. Locke DE, Decker PA, Sloan JA, et al: Validation of single-item linear analog scale assessment of quality of life in neuro-oncology patients. J Pain Symptom Manage 34:628-638, 2007
30. Sloan JA, Berk L, Roscoe J, et al: Integrating patient-reported outcomes into cancer symptom management clinical trials supported by the National Cancer Institute-sponsored clinical trials networks. J Clin Oncol 25:5070-5077, 2007
31. Aaronson NK: Quality of life: What is it? How should it be measured? Oncology (Williston Park) 2:69-76, 64, 1988
32. Levine MN, Ganz PA: Beyond the development of quality-of-life instruments: Where do we go from here? J Clin Oncol 20:2215-2216, 2002
33. Osoba D: A taxonomy of the uses of health-related quality-of-life instruments in cancer care and the clinical meaningfulness of the results. Med Care 40:III31-III38, 2002 (suppl)
34. Till JE, Osoba D, Pater JL, et al: Research on health-related quality of life: Dissemination into practical applications. Qual Life Res 3:279-283, 1994
35. Yao M, Karnell LH, Funk GF, et al: Health-related quality-of-life outcomes following IMRT versus conventional radiotherapy for oropharyngeal squamous cell carcinoma. Int J Radiat Oncol Biol Phys 69:1354-1360, 2007
36. Velikova G, Awad N, Coles-Gale R, et al: The clinical value of quality of life assessment in oncology practice-a qualitative study of patient and physician views. Psychooncology 17:690-698, 2008
37. Greenhalgh J, Long AF, Brettle AJ, et al: Reviewing and selecting outcome measures for use in routine practice. J Eval Clin Pract 4:339-350, 1998
38. Greenhalgh J, Meadows K: The effectiveness of the use of patient-based measures of health in routine practice in improving the process and outcomes of patient care: A literature review. J Eval Clin Pract 5:401-416, 1999
39. Frost MH, Bonomi AE, Cappelleri JC, et al: Applying quality-of-life data formally and systematically into clinical practice. Mayo Clin Proc 82:1214-1228, 2007
40. Snyder CF, Aaronson NK, Choucair AK, et al: Implementing patient-reported outcomes assessment in clinical practice: A review of the options and considerations. Qual Life Res 21:1305-1314, 2012
41. Lohr KN, Zebrack BJ: Using patient-reported outcomes in clinical practice: Challenges and opportunities. Qual Life Res 18:99-107, 2009
42. Detmar SB, Muller MJ, Schornagel JH, et al: Health-related quality-of-life assessments and patient-physician communication: A randomized controlled trial. JAMA 288:3027-3034, 2002
43. Velikova G, Booth L, Smith AB, et al: Measuring quality of life in routine oncology practice improves communication and patient well-being: A randomized controlled trial. J Clin Oncol 22:714-724, 2004
44. Velikova G, Keding A, Harley C, et al: Patients report improvements in continuity of care when quality of life assessments are used routinely in oncology practice: Secondary outcomes of a randomised controlled trial. Eur J Cancer 46:2381-2388, 2010
45. Buchanan DR, White JD, O'Mara AM, et al: Research-design issues in cancer-symptom-management trials using complementary and alternative medicine: Lessons from the National Cancer Institute Community Clinical Oncology Program experience. J Clin Oncol 23:6682-6689, 2005
46. Buchanan DR, O'Mara AM, Kelaghan JW, et al: Quality-of-life assessment in the symptom management trials of the National Cancer Institute-supported Community Clinical Oncology Program. J Clin Oncol 23:591-598, 2005
47. Watanabe SM, Nekolaichuk CL, Beaumont C: The Edmonton Symptom Assessment System, a proposed tool for distress screening in cancer patients: Development and refinement. Psychooncology 21:977-985, 2012
48. Jones D, Zhao F, Fisch MJ, et al: The validity and utility of the MD Anderson Symptom Inventory in patients with prostate cancer: Evidence from the symptom outcomes and practice patterns (SOAPP) data from the Eastern Cooperative Oncology Group. Clin Genitourin Cancer 12:41-49, 2014
49. Sloan JA, Cella D, Frost MH, et al: Quality of life III: Translating the science of quality-of-life assessment into clinical practice-an example-driven approach for practicing clinicians and clinical researchers. Clin Ther 25:D1-D5, 2003 (suppl D)
50. Cleeland CS, Sloan JA, Cella D, et al: Recommendations for including multiple symptoms as endpoints in cancer clinical trials: A report from the ASCPRO (Assessing the Symptoms of Cancer Using Patient-Reported Outcomes) Multi-symptom Task Force. Cancer 119:411-420, 2013